• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蠕虫感染的健康指标。

Health metrics for helminth infections.

作者信息

King Charles H

机构信息

Center for Global Health and Diseases, Case Western Reserve University School of Medicine, 2109 Adelbert Road, BRB Room 422, Cleveland, OH 44106, USA.

出版信息

Acta Trop. 2015 Jan;141(Pt B):150-60. doi: 10.1016/j.actatropica.2013.12.001. Epub 2013 Dec 12.

DOI:10.1016/j.actatropica.2013.12.001
PMID:24333545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4055550/
Abstract

Health metrics based on health-adjusted life years have become standard units for comparing the disease burden and treatment benefits of individual health conditions. The Disability-Adjusted Life Year (DALY) and the Quality-Adjusted Life Year (QALY) are the most frequently used in cost-effect analyses in national and global health policy discussions for allocation of health care resources. While sometimes useful, both the DALY and QALY metrics have limitations in their ability to capture the full health impact of helminth infections and other 'neglected tropical diseases' (NTDs). Gaps in current knowledge of disease burden are identified, and interim approaches to disease burden assessment are discussed.

摘要

基于健康调整生命年的健康指标已成为比较个体健康状况的疾病负担和治疗效益的标准单位。伤残调整生命年(DALY)和质量调整生命年(QALY)是国家和全球卫生政策讨论中用于卫生保健资源分配的成本效益分析中最常用的指标。虽然有时有用,但DALY和QALY指标在全面反映蠕虫感染和其他“被忽视的热带病”(NTDs)对健康的影响方面都存在局限性。本文指出了当前疾病负担知识方面的差距,并讨论了疾病负担评估的临时方法。

相似文献

1
Health metrics for helminth infections.蠕虫感染的健康指标。
Acta Trop. 2015 Jan;141(Pt B):150-60. doi: 10.1016/j.actatropica.2013.12.001. Epub 2013 Dec 12.
2
Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.血吸虫病和土壤传播性蠕虫病的全社区综合药物治疗策略比较:成本效益建模研究。
Lancet Glob Health. 2015 Oct;3(10):e629-38. doi: 10.1016/S2214-109X(15)00047-9.
3
Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases.贫困的不对称性:为什么全球疾病负担评估低估了被忽视热带病的负担。
PLoS Negl Trop Dis. 2008 Mar 26;2(3):e209. doi: 10.1371/journal.pntd.0000209.
4
Disability-Adjusted Life Years Following Adult Out-of-Hospital Cardiac Arrest in the United States.美国成人院外心脏骤停后的伤残调整生命年
Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e004677. doi: 10.1161/CIRCOUTCOMES.118.004677.
5
Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity.被忽视热带病的疾病控制重点:基于证据质量、成本效益、疾病严重程度、灾难性卫生支出和生产力损失进行优先级排序的经验教训。
Dev World Bioeth. 2014 Dec;14(3):132-41. doi: 10.1111/dewb.12016. Epub 2013 May 31.
6
Measure-dependent variation in burden of disease estimates: implications for policy.疾病负担估计中因测量方法而异的差异:对政策的影响。
Med Care. 2002 Mar;40(3):260-6. doi: 10.1097/00005650-200203000-00009.
7
Impact of a Nonfatal Dengue Episode on Disability-Adjusted Life Years: A Systematic Analysis.非重症登革热发病对伤残调整生命年的影响:系统分析。
Am J Trop Med Hyg. 2018 Dec;99(6):1458-1465. doi: 10.4269/ajtmh.18-0309.
8
Assessing the disease burden due to epilepsy by disability adjusted life year in rural China.通过伤残调整生命年评估中国农村地区癫痫所致的疾病负担。
Epilepsia. 2006 Dec;47(12):2032-7. doi: 10.1111/j.1528-1167.2006.00802.x.
9
Measuring the population burden of fatal and nonfatal injury.测量致命和非致命伤害的人口负担。
Epidemiol Rev. 2012;34:17-31. doi: 10.1093/epirev/mxr022. Epub 2011 Nov 23.
10
Global Patterns in Health Burden of Uncorrected Refractive Error.未矫正屈光不正所致健康负担的全球模式
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6271-6277. doi: 10.1167/iovs.16-20242.

引用本文的文献

1
Altered purinergic P2X7 and A receptors signaling limits macrophage-mediated host defense in schistosomiasis.嘌呤能P2X7和A受体信号改变限制了血吸虫病中巨噬细胞介导的宿主防御。
Biomed J. 2024 Dec;47(6):100713. doi: 10.1016/j.bj.2024.100713. Epub 2024 Mar 3.
2
A simple parasitological technique to increase detection of Strongyloides stercoralis in Bolivian primary health care system.一种简单的寄生虫学技术,可提高玻利维亚初级卫生保健系统中对粪类圆线虫的检测率。
BMC Prim Care. 2022 Nov 17;23(1):284. doi: 10.1186/s12875-022-01888-4.
3
Development of a New LAMP Assay for the Detection of DNA (Copro-LAMPAc) in Dog Fecal Samples.

本文引用的文献

1
Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study.肯尼亚曼氏血吸虫病流行区儿童健康相关生命质量评估:一项横断面研究。
PLoS Negl Trop Dis. 2013;7(3):e2106. doi: 10.1371/journal.pntd.0002106. Epub 2013 Mar 7.
2
A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni.五国现场循环阴极抗原尿液检测法评估曼氏血吸虫病流行率。
Am J Trop Med Hyg. 2013 Mar;88(3):426-432. doi: 10.4269/ajtmh.12-0639. Epub 2013 Jan 21.
3
Impact of polyparasitic infections on anemia and undernutrition among Kenyan children living in a Schistosoma haematobium-endemic area.
用于检测犬粪便样本中DNA(粪便环介导等温扩增法)的新型环介导等温扩增检测方法的开发。
Front Vet Sci. 2021 Nov 12;8:770508. doi: 10.3389/fvets.2021.770508. eCollection 2021.
4
Natural Products Are a Promising Source for Anthelmintic Drug Discovery.天然产物是抗蠕虫药物发现的有前途的来源。
Biomolecules. 2021 Oct 4;11(10):1457. doi: 10.3390/biom11101457.
5
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations.用于为医疗保健中的优先事项设定和资源分配提供信息的主要类型经济评估简介:主要特点、用途和局限性。
Front Public Health. 2021 Aug 25;9:722927. doi: 10.3389/fpubh.2021.722927. eCollection 2021.
6
Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?现行的控制和消除被忽视热带病的预防化疗策略是否具有成本效益?
BMJ Glob Health. 2021 Aug;6(8). doi: 10.1136/bmjgh-2021-005456.
7
Quality of Life Assessment Among Patients Living With Hepatosplenic Schistosomiasis and Schistosomal Myeloradiculopathy.肝脾型血吸虫病和血吸虫性脊髓神经根病患者的生活质量评估
Front Med (Lausanne). 2021 Jun 1;8:629484. doi: 10.3389/fmed.2021.629484. eCollection 2021.
8
The Functional Parasitic Worm Secretome: Mapping the Place of Excretory Secretory Products.功能性寄生蠕虫分泌蛋白质组:绘制排泄分泌产物的定位图
Pathogens. 2020 Nov 23;9(11):975. doi: 10.3390/pathogens9110975.
9
Clinical helminthiases in Thailand border regions show elevated prevalence levels using qPCR diagnostics combined with traditional microscopic methods.泰国边境地区的临床寄生虫病采用 qPCR 诊断与传统显微镜方法相结合,显示出较高的流行水平。
Parasit Vectors. 2020 Aug 12;13(1):416. doi: 10.1186/s13071-020-04290-0.
10
Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.在肯尼亚西部,经过四年的吡喹酮大规模药物治疗后,评估曼氏血吸虫阳性的小学生和中学生的发病率。
Infect Dis Poverty. 2020 Jun 15;9(1):67. doi: 10.1186/s40249-020-00690-7.
肯尼亚血吸虫病流行地区儿童的多寄生虫感染对贫血和营养不良的影响。
Am J Trop Med Hyg. 2013 Mar;88(3):433-40. doi: 10.4269/ajtmh.12-0552. Epub 2013 Jan 16.
4
Disability weights for vision disorders in Global Burden of Disease study - Authors' reply.《全球疾病负担研究中视力障碍的残疾权重——作者回复》
Lancet. 2013 Jan 5;381(9860):23-4. doi: 10.1016/S0140-6736(12)62131-X. Epub 2012 Dec 21.
5
Disability weights for vision disorders in Global Burden of Disease study.全球疾病负担研究中视力障碍的残疾权重
Lancet. 2013 Jan 5;381(9860):23. doi: 10.1016/S0140-6736(12)62081-9. Epub 2012 Dec 21.
6
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.291 种疾病和伤害导致的伤残调整生命年(DALYs)在 21 个地区,1990-2010 年:全球疾病负担研究 2010 的系统分析。
Lancet. 2012 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.
7
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.2010 年全球疾病负担研究:1990-2010 年 289 种疾病和伤害的 1160 种后遗症导致的残疾生存年数的系统分析。
Lancet. 2012 Dec 15;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2.
8
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.评估疾病和损伤所致健康结果的共同价值观:用于 2010 年全球疾病负担研究的残疾权重测量研究。
Lancet. 2012 Dec 15;380(9859):2129-43. doi: 10.1016/S0140-6736(12)61680-8.
9
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
10
GBD 2010: design, definitions, and metrics.《2010年全球疾病负担研究:设计、定义与衡量指标》
Lancet. 2012 Dec 15;380(9859):2063-6. doi: 10.1016/S0140-6736(12)61899-6.